Author: Laura Riva; Shuofeng Yuan; Xin Yin; Laura Martin-Sancho; Naoko Matsunaga; Sebastian Burgstaller-Muehlbacher; Lars Pache; Paul P. De Jesus; Mitchell V. Hull; Max Chang; Jasper Fuk-Woo Chan; Jianli Cao; Vincent Kwok-Man Poon; Kristina Herbert; Tu-Trinh Nguyen; Yuan Pu; Courtney Nguyen; Andrey Rubanov; Luis Martinez-Sobrido; Wen-Chun Liu; Lisa Miorin; Kris M. White; Jeffrey R. Johnson; Christopher Benner; Ren Sun; Peter G. Schultz; Andrew Su; Adolfo Garcia-Sastre; Arnab K. Chatterjee; Kwok-Yung Yuen; Sumit K. Chanda
Title: A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals Document date: 2020_4_17
ID: 1fgnfh62_29
Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.16.044016 doi: bioRxiv preprint all been shown to efficiently block either SARS-CoV-1 or 2 infection in vitro or in vivo [46] [47] [48] [49] [50] , thus assessing the sensitivity of our screening conditions in identifying compounds with known antiviral activity ( Figure 1B, top right middle panel) ......
Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.16.044016 doi: bioRxiv preprint all been shown to efficiently block either SARS-CoV-1 or 2 infection in vitro or in vivo [46] [47] [48] [49] [50] , thus assessing the sensitivity of our screening conditions in identifying compounds with known antiviral activity ( Figure 1B, top right middle panel) .
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date